CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale SVP, Finance and Accounting sold 1,990 shares at $1.38 ($2,747)
- 4 Option exercise SVP, Finance and Accounting acquired 6,875 shares (option exercise)
- 4 Option exercise CEO acquired 37,500 shares (option exercise)
- 4 Option exercise Chief Business Officer acquired 11,250 shares (option exercise)
- 4 Option exercise General Counsel acquired 11,250 shares (option exercise)
- 4 Option exercise SVP, Chief Scientific Officer acquired 11,250 shares (option exercise)
- 4 Open-market sale SVP, Chief Scientific Officer sold 4,119 shares at $1.30 ($5,356)
- 4 Open-market sale Chief Business Officer sold 4,119 shares at $1.30 ($5,356)
- 4 Open-market sale CEO sold 14,601 shares at $1.30 ($18,987)
- 4 Open-market sale General Counsel sold 5,486 shares at $1.30 ($7,135)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise CEO acquired 16,535 shares (option exercise)
- 4 Open-market buy Director bought 5,000 shares at $1.55 ($7,750)
Page 5 of 20 · 400 filings